Interview: Debashis Ghosh, Vice President & Global Head, Tata Consultancy…
TCS Life Sciences and Healthcare vertical was created within the Tata Group 10 years ago. Can you explain to the…
Address: PTI Building 4 Parliament Street, New Delhi 110001 India
Tel: +91 11 66506555
Web: http://www.tcs.com/Pages/default.aspx
Tata Consultancy Services Limited (TCS) (BSE: 532540, NSE: TCS) is an Indian IT services, business solutions and outsourcing company headquartered in Mumbai, India. TCS is the largest provider of information technology in Asia and second largest provider of business process outsourcing services in India. TCS has offices in 47 countries with more than 142 branches across the globe. The company is listed on the National Stock Exchange and Bombay Stock Exchange of India. TCS is ranked at 21 in the list of global IT services ranking of service providers. Recently the market cap of TCS reached $ 52 billions making it one of the biggest companies in the IT sector in the world.
TCS is one of the operative subsidiaries of one of India’s largest and oldest conglomerate company, the Tata Group or Tata Sons Limited, which has interests in areas such as energy, telecommunications, financial services, manufacturing, chemicals, engineering, materials, government and healthcare.
-IT Services
-IT Infrastructure Services
-Enterprise Solutions
-Consulting
-Business Process Outsourcing
-Business Intelligence and Performance Management
-Engineering and Industrial Services
-Small and Medium Business
-Connected Marketing Solutions
TCS Life Sciences and Healthcare vertical was created within the Tata Group 10 years ago. Can you explain to the…
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the…
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the…
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…